CYCLOSPORINE NEORAL IN LIVER-TRANSPLANT RECIPIENTS

被引：0

作者：

LEVY, G ^{[1
]}

ALTRAIF, I ^{[1
]}

REZIEG, M ^{[1
]}

ASFAR, S ^{[1
]}

ROCHON, J ^{[1
]}

FREEMAN, D ^{[1
]}

WONG, PY ^{[1
]}

BANKS, L ^{[1
]}

ROACH, C ^{[1
]}

ENGEL, K ^{[1
]}

GRANT, D ^{[1
]}

机构：

[1] UNIV WESTERN ONTARIO HOSP,LONDON,ON,CANADA

来源：

TRANSPLANTATION PROCEEDINGS | 1994年 / 26卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：3184 / 3187

页数：4

共 20 条

[1] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT [J].

BOREL, JF ;

FEURER, C ;

GUBLER, HU ;

STAHELIN, H .

AGENTS AND ACTIONS, 1976, 6 (04) :468-475

[2] CYCLOSPORINE AS A NEW APPROACH TO THERAPY OF AUTOIMMUNE-DISEASES [J].

BOREL, JF ;

GUNN, HC .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 475 :307-319

[3] CYCLOSPORINE ABSORPTION FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION [J].

BURCKART, GJ ;

VENKATARAMANAN, R ;

PTACHCINSKI, RJ ;

STARZL, TE ;

GARTNER, JC ;

ZITELLI, BJ ;

MALATACK, JJ ;

SHAW, BW ;

IWATSUKI, S ;

VANTHIEL, DH .

JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (08) :647-651

[4]

GUPTA SK, 1989, CLIN PHARMACOL THER, V45, P148

[5]

HESS AD, 1986, PROG ALLERGY, V38, P198

[6]

KAHAN BD, 1989, NEW ENGL J MED, V321, P1725

[7] INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS [J].

KAHAN, BD .

TRANSPLANTATION, 1985, 40 (05) :457-476

[8]

KEOWN PA, 1982, TRANSPLANT P, V14, P659

[9]

LAUPACIS A, 1982, CAN MED ASSOC J, V126, P1041

[10]

LEMAIRE M, 1990, TRANSPLANT P, V22, P1110

← 1 2 →